National Cancer Institute, Notice of Meeting, 15315 [2016-06335]
Download as PDF
15315
Federal Register / Vol. 81, No. 55 / Tuesday, March 22, 2016 / Notices
2016, Vol. 81 pp.1633 and allowed 60days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The
National Cancer Institute (NCI),
National Institutes of Health (NIH), may
not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: NIH
Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
scale cancer genomic data and
associated clinical information. The goal
of this effort is to develop an innovative,
cost-effective model for computational
analysis of biological data and provide
broader yet secure access to genomic
data that NCI generates. Cloud
computing will be a valuable tool to
support studies related to the
mechanisms of cancer. This capability
will be equally valuable to other NCI
scientific areas, including clinical trials
and other types of patient-focused
research. In order to understand the
utility and value of the tools being
developed, the NCI has developed a
survey instrument to capture feedback
from the cancer research community.
The information collected as part of this
survey process will be used exclusively
by the NCI to determine future funding
of cloud technology projects.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
375.
To
obtain a copy of the data collection
plans and instruments, or request more
information on the proposed project,
contact: Anthony Kerlavage, NCI CBIIT,
Program Manager, 9609 Medical Center
Drive, Room 1W–436, Rockville, MD
20850 or call non-toll-free number 240–
276–5190 or email your request,
including your address to:
anthony.kerlavage@nih.gov. Formal
requests for additional plans and
instruments must be requested in
writing.
Proposed Collection: Cancer
Genomics Cloud Pilots Survey, 0925–
NEW, National Cancer Institute (NCI),
National Institutes of Health (NIH).
Need and Use of Information
Collection Need and Use of Information
Collection: The Center for Biomedical
Informatics and Information Technology
(CBIIT), in collaboration with the Center
for Cancer Genomics at the National
Cancer Instititues (NCI) in the National
Institutes of Health (NIH), is
coordinating a program to develop three
Cancer Genomics Cloud Pilots to help
meet the research community’s needs to
access and analyze high quality, large-
FOR FURTHER INFORMATION CONTACT:
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total annual
burden hour
Form name
Type of respondent
Cloud Pilot Survey ............................
Principal Investigator ........................
1500
1
15/60
375
Totals .........................................
...........................................................
1500
1500
........................
375
Dated: March 14, 2016.
Karla Bailey,
Project Clearance Liaison, National Cancer
Institute, NIH.
notify the Contact Person listed below
in advance of the meeting.
[FR Doc. 2016–06332 Filed 3–21–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
asabaliauskas on DSK3SPTVN1PROD with NOTICES
National Cancer Institute, Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the meeting of the
President’s Cancer Panel.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
VerDate Sep<11>2014
17:34 Mar 21, 2016
Jkt 238001
Name of Committee: President’s Cancer
Panel.
Date: June 10, 2016.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: Examining the Cancer Drug Cost
and Access Landscape.
Place: New York Hilton Midtown, 1335
Avenue of the Americas, New York, NY
10019.
Contact Person: Abby B. Sandler, Ph.D.,
Executive Secretary, President’s Cancer
Panel, Special Assistant to the Director, NCI
Center for Cancer Research, 9000 Rockville
Pike, Building 31, Room B2B37, MSC 2590,
Bethesda, MD 20892–8349, 301–451–9399,
sandlera@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/pcp/index.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
PO 00000
Frm 00096
Fmt 4703
Sfmt 4703
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: March 16, 2016.
Melanie Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–06335 Filed 3–21–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Final Action Under the NIH Guidelines
for Research Involving Recombinant or
Synthetic Nucleic Acid Molecules (NIH
Guidelines)
National Institutes of Health
(NIH), HHS.
ACTION: Notice of changes to the NIH
Guidelines.
AGENCY:
E:\FR\FM\22MRN1.SGM
22MRN1
Agencies
[Federal Register Volume 81, Number 55 (Tuesday, March 22, 2016)]
[Notices]
[Page 15315]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-06335]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute, Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the meeting of the
President's Cancer Panel.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: President's Cancer Panel.
Date: June 10, 2016.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: Examining the Cancer Drug Cost and Access Landscape.
Place: New York Hilton Midtown, 1335 Avenue of the Americas, New
York, NY 10019.
Contact Person: Abby B. Sandler, Ph.D., Executive Secretary,
President's Cancer Panel, Special Assistant to the Director, NCI
Center for Cancer Research, 9000 Rockville Pike, Building 31, Room
B2B37, MSC 2590, Bethesda, MD 20892-8349, 301-451-9399,
sandlera@mail.nih.gov.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/pcp/index.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: March 16, 2016.
Melanie Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-06335 Filed 3-21-16; 8:45 am]
BILLING CODE 4140-01-P